These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35453591)

  • 1. Treatment of Painful Palmoplantar Keratoderma Related to Pachyonychia Congenita Using EGFR Inhibitors.
    Greco C; Ponsen AC; Leclerc-Mercier S; Schlatter J; Cisternino S; Boucheix C; Bodemer C
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.
    Zieman AG; Coulombe PA
    Br J Dermatol; 2020 Mar; 182(3):564-573. PubMed ID: 31021398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib.
    Basset J; Marchal L; Hovnanian A
    J Invest Dermatol; 2023 Feb; 143(2):294-304.e8. PubMed ID: 36116508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations.
    Greco C; Leclerc-Mercier S; Chaumon S; Doz F; Hadj-Rabia S; Molina T; Boucheix C; Bodemer C
    JAMA Dermatol; 2020 Feb; 156(2):191-195. PubMed ID: 31895432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotypic and molecular genetic features of pachyonychia congenita.
    McLean WH; Hansen CD; Eliason MJ; Smith FJ
    J Invest Dermatol; 2011 May; 131(5):1015-7. PubMed ID: 21430705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
    Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
    Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children.
    Goldberg I; Mashiah J; Kutz A; Derowe A; Warshauer E; Schwartz ME; Smith F; Sprecher E; Hansen CD
    Br J Dermatol; 2020 Mar; 182(3):708-713. PubMed ID: 31777952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jadassohn Lewandowsky Syndrome: A Rare Entity.
    Prasad AM; Inakanti Y; Kumar S
    Indian J Dermatol; 2015; 60(5):524. PubMed ID: 26538744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.
    Lessard JC; Coulombe PA
    J Invest Dermatol; 2012 May; 132(5):1384-91. PubMed ID: 22336941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
    Samuelov L; Smith FJD; Hansen CD; Sprecher E
    Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pachyonychia congenita type 2 (Jackson-Lawler syndrome) or PC-17: case report.
    Morais P; Peralta L; Loureiro M; Coelho S
    Acta Dermatovenerol Croat; 2013; 21(1):48-51. PubMed ID: 23683487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pachyonychia Congenita (K16) with Unusual Features and Good Response to Acitretin.
    Almutawa F; Thusaringam T; Watters K; Gayden T; Jabado N; Sasseville D
    Case Rep Dermatol; 2015; 7(2):220-6. PubMed ID: 26464567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.
    Sharma S; Dayal S; Aggarwal K; Gowda V M V; Kaur R
    Australas J Dermatol; 2022 May; 63(2):e145-e149. PubMed ID: 35429339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pachyonychia congenita - pathogenesis of pain and approaches to treatment.
    McCarthy RL; de Brito M; O'Toole EA
    Clin Exp Dermatol; 2024 May; ():. PubMed ID: 38805703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized bullae in a young girl with KRT6A-related pachyonychia congenita.
    Liu J; Zhong W; Yu B; Lin Z; Zheng Y; Hu X
    Pediatr Dermatol; 2020 Sep; 37(5):974-976. PubMed ID: 32662074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two for two: Dual therapy with erlotinib and acitretin for twins with severe keratoderma in Olmsted syndrome.
    Butala S; Phan S; Siegel DH; Carlberg V; Paller AS
    Pediatr Dermatol; 2023; 40(4):735-737. PubMed ID: 36709954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pachyonychia congenita: A rare genodermatosis.
    Agarwal P; Chhaperwal MK; Singh A; Verma A; Nijhawan M; Singh K; Mathur D
    Indian Dermatol Online J; 2013 Jul; 4(3):225-7. PubMed ID: 23984242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pachyonychia congenita with late onset (PC tarda).
    Sravanthi A; Srivalli P; Gopal KV; Rao TN
    Indian Dermatol Online J; 2016; 7(4):278-80. PubMed ID: 27559502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual Dimorphism in Response to an NRF2 Inducer in a Model for Pachyonychia Congenita.
    Kerns ML; Hakim JMC; Zieman A; Lu RG; Coulombe PA
    J Invest Dermatol; 2018 May; 138(5):1094-1100. PubMed ID: 29277538
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.